questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of NICE condition severity ratings on the accessibility of drugs for those with secondary breast cancer.
answerText: he latest data for technology appraisals published up until the end of September 2025 shows that the National Institute for Health and Care Excellence (NICE) has recommended a greater proportion of medicines for advanced cancer since the severity modifier...
heading: Breast Cancer: Drugs